Posted on 6/22/18
Is Sarepta Therapeutics Stock Headed to Over $200 a Share?
Wall Street is enamored with the rare-disease drugmaker Sarepta Therapeutics(NASDAQ:SRPT). Despite this stock's 166% surge this year, after all, analysts have been quick to upgrade the . . .
Posted on 6/21/18
Surface Oncology Recognized as One of the “Best Places to Work” by Boston Business Journal
CAMBRIDGE, Mass., June 21, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that . . .
Posted on 6/21/18
Flexion Therapeutics Named One of Boston Business Journal’s Best Places to Work for the Second Year in a Row
BURLINGTON, Mass., June 21, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has been named as one of the Boston Business Journal’s . . .
Posted on 6/21/18
Peak Physical Therapy & Sports Performance Talks Back Safety at Norwell High
Eric Edelman, PT and owner of Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive treatment in orthopedic, . . .
Posted on 6/21/18
Bionik Laboratories Announces Agreement with The Transitional Learning Center
Bionik Laboratories Corp. (OTCQB: BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to . . .
Posted on 6/21/18
Seaward Management Announces Rebrand to Prio Wealth
Seaward Management, a Boston based wealth management firm, today announced the business' rebrand to Prio Wealth – reinforcing the company's focus on financial life management and . . .
Posted on 6/21/18
ImmunoGen Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the underwriters . . .
Posted on 6/21/18
InVivo Therapeutics Prices $13.2 Million Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced the pricing of an underwritten public offering of 388,403 shares of its common stock, together with warrants . . .
Posted on 6/21/18
Histogenics (HSGX) Investor Presentation - Slideshow
The following slide deck was published by Histogenics Corporation in conjunction with this event. 155READ FULL ARTICLE HERE
Posted on 6/21/18
Why Anika Therapeutics, Inc. Stock Is Sinking
What happenedShares of Anika Therapeutics Inc (NASDAQ:ANIK), a small-cap biotech focused on regenerative medicine, were down 36% as of 11:10 a.m. EDT on Tuesday. The stock . . .
Posted on 6/21/18
Magenta Therapeutics Prices IPO
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics, Inc., a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patients, today announced . . .
Posted on 6/21/18
AVROBIO Announces Pricing of Initial Public Offering
CAMBRIDGE, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc., a Phase 2 clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral-based . . .
Posted on 6/21/18
Medisafe Announces Partnership with Boehringer Ingelheim
Medisafe®, the leading personalized mobile health platform for medication management with over four million patient and caregiver users globally, today unveiled a partnership with Boehringer Ingelheim . . .
Posted on 6/20/18
Aquinnah Pharmaceuticals Receives $3.4M Grant from NINDS To Advance New Therapies for ALS
Aquinnah Pharmaceuticals, leaders in stress granule biology, an exciting new target for the development of neurodegenerative therapeutics, announced today that it has been awarded $3.4 million . . .
Posted on 6/20/18
Catabasis Pharmaceuticals Announces Pricing of $42 Million Underwritten Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten offering of an aggregate of 42,000,000 units. Each unit is . . .
Posted on 6/20/18
Spectro Scientific Introduces TruVu 360 Enterprise Fluid Intelligence Platform
CHELMSFORD, Mass.--(BUSINESS WIRE)--Spectro Scientific, one of the world’s largest suppliers of oil, fuel, and processed-water analysis instrumentation and software, has introduced TruVu 360 Enterprise Fluid Intelligence . . .
Posted on 6/20/18
MedeAnalytics Announces Partnership with HealthEdge
MedeAnalytics, a pioneer in health care analytics for payers and providers, and HealthEdge, provider of the only integrated financial, administrative and clinical platform for transformative health . . .
Posted on 6/20/18
Translate Bio Prepares For $100 Million U.S. IPO
Quick TakeTranslate Bio (TBIO) intends to sell shares of its common stock to raise $100 million from a U.S. IPO, according to an S-1/A registration statement.The . . .
Posted on 6/20/18
CVS Health Recognized as One of The 50 Most Community-Minded Companies by Points of Light for Second Consecutive Year
For the second year in a row, CVS Health [NYSE:CVS] has been named an honoree of The Civic 50 by Points of Light, the world's largest . . .
Posted on 6/19/18
SetPoint Medical Reports Positive 2-Year Results for Bioelectronic Medicine to Treat Rheumatoid Arthritis
SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced positive long-term data for its first-in-human study using bioelectronic medicine for . . .
Posted on 6/19/18
Karuna Receives $8 Million Wellcome Trust Award
BOSTON--(BUSINESS WIRE)--Karuna Pharmaceuticals, an affiliate of PureTech Health plc (LSE: PRTC), focused on targeting muscarinic receptors for the treatment of disorders marked by psychosis and cognitive . . .
Posted on 6/19/18
Decibel Therapeutics Closes $55 Million Series C Financing
BOSTON--(BUSINESS WIRE)--Decibel Therapeutics, a company dedicated to the discovery and development of breakthrough medicines to treat hearing loss and hearing-related disorders, today announced that it has . . .
Posted on 6/19/18
Medisafe Announces Partnership with Boehringer Ingelheim
Medisafe, the leading personalized mobile health platform for medication management with over four million patient and caregiver users globally, today unveiled a partnership with Boehringer Ingelheim . . .
Posted on 6/19/18
CVS And Aetna Are Changing The Healthcare Paradigm
Market OutlookWith the recent proposed purchase of Aetna (NYSE:AET), CVS (NYSE:CVS) has positioned itself as the only player in the market with such a significant market . . .
Posted on 6/19/18
Bluebird Bio (BLUE) LentiGlobin Drug Overview - Slideshow
The following slide deck was published by bluebird bio, Inc. in conjunction with this event. 129READ FULL ARTICLE HERE

